Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04933669` - Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors	Phase 2
Completed	`NCT01769248` - Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle	N/A
Completed	`NCT01774162` - EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration	N/A
Terminated	`NCT00091078` - Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery	Phase 2
Completed	`NCT00025246` - Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery	Phase 2
Active, not recruiting	`NCT00265798` - Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate	Phase 2
Recruiting	`NCT04143048` - A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules
Recruiting	`NCT02931981` - Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor	N/A
Not yet recruiting	`NCT02576080` - Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index	Phase 3
Recruiting	`NCT01389583` - A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients	Phase 2
Recruiting	`NCT00777504` - Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors	Phase 4
Completed	`NCT00764595` - Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor	Phase 2
Completed	`NCT00769782` - Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor	Phase 2
Completed	`NCT00098579` - Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery	Phase 1
Completed	`NCT00005862` - SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas	Phase 2
Completed	`NCT00004895` - Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	Phase 2
Recruiting	`NCT02776878` - A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST	N/A
Completed	`NCT01751919` - A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)	Phase 1
Completed	`NCT01267695` - Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor	Phase 2
Terminated	`NCT00956072` - Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate	Phase 3

NCT number	NCT01110668
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	September 2008
Completion date	September 2011

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms